sertraline has been researched along with Cardiovascular Stroke in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 18 (69.23) | 29.6817 |
2010's | 6 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, W; Qin, J | 1 |
Haskell, SE; Hermann, GM; Peotta, VA; Reinking, BE; Roghair, RD | 1 |
Austin, PC; Gomes, T; Ho, JM; Juurlink, DN; Mamdani, M; Straus, SE | 1 |
Bah, TM; Boucher, M; Dufort, AM; Godbout, R; Kaloustian, S; Le Marec, N; Rousseau, G; Wann, BP | 1 |
Barbour, K; Burg, M; Jaffe, A; Taylor, CB; Trockel, M | 1 |
Douzenis, A; Flevari, P; Ikonomidis, I; Iliodromitis, E; Kremastinos, DT; Leftheriotis, D; Liapis, C; Lykouras, L; Paraskevaidis, I | 1 |
Carney, RM; Freedland, KE; Harris, WS; Krone, RJ; Rich, MW; Rubin, EH; Stein, PK; Steinmeyer, BC | 1 |
Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
Deuschle, M | 1 |
Barton, D; Bigger, JT; Califf, RM; Finkel, MS; Glassman, AH; Harrison, WM; Krishnan, KR; Landau, C; Mardekian, J; Mclvor, M; O'Connor, CM; Pepine, CJ; Schwartz, P; Shapiro, PA; Swedberg, K; Swenson, JR; van Zyl, LT | 1 |
Carney, RM; Jaffe, AS | 1 |
Steinberg, DI | 1 |
Frasure-Smith, N; Lespérance, F | 1 |
Flynn, DM; Hill, RJ; Knight, DR; Magee, WP; Oleynek, JJ; Smith, AH; Tracey, WR | 1 |
Friedman, EH | 1 |
Glassman, AH; Harrison, DJ; O'Connor, CM | 1 |
Le Mellédo, JM; Perez, J | 1 |
Burg, MM; Cornell, CE; Cowan, MJ; Czajkowski, SM; Freedland, KE; Powell, LH; Saab, PG; Youngblood, ME | 1 |
Baker, B; Dorian, P; Frasure-Smith, N; Glassman, AH; Harrison, W; Jiang, JW; Lespérance, F; O'Connor, CM; Shapiro, PA | 1 |
Gattis, WA; Gurbel, PA; Murugesan, SR; Nair, GV; O'Connor, CM; Serebruany, VL | 1 |
Cherian, F; Fallen, EL; Kamath, MV; Malcolm, V; McFarlane, A; Norman, G | 1 |
Härter, M; Hesslinger, B; Klecha, D; Schmidt-Schweda, S; Van de Loo, A | 1 |
1 review(s) available for sertraline and Cardiovascular Stroke
Article | Year |
---|---|
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Blood Platelets; Clinical Trials as Topic; Depression; Humans; Myocardial Infarction; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
9 trial(s) available for sertraline and Cardiovascular Stroke
Article | Year |
---|---|
Clinical efficacy and safety of the Shugan Jieyu capsule in patients with acute myocardial infarction and depression.
Topics: Aged; Antidepressive Agents; Depressive Disorder; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline; Treatment Outcome | 2016 |
Smoking behavior postmyocardial infarction among ENRICHD trial participants: cognitive behavior therapy intervention for depression and low perceived social support compared with care as usual.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depressive Disorder; Depressive Disorder, Major; Dysthymic Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Sick Role; Smoking; Smoking Cessation; Social Support | 2008 |
Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.
Topics: Circadian Rhythm; Comorbidity; Coronary Disease; Depressive Disorder; Drug Therapy, Combination; Electrocardiography, Ambulatory; Fatty Acids, Omega-3; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Sertraline; Treatment Outcome | 2010 |
Sertraline treatment of major depression in patients with acute MI or unstable angina.
Topics: Angina, Unstable; Depressive Disorder, Major; Double-Blind Method; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Treating depression after a heart attack.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Myocardial Infarction; Reference Values; Sertraline; Severity of Illness Index; Treatment Outcome | 2002 |
Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.
Topics: Angina, Unstable; Cardiac Catheterization; Cost-Benefit Analysis; Depressive Disorder; Diagnosis-Related Groups; Double-Blind Method; Drug Costs; Emergency Service, Hospital; Fee Schedules; Female; Health Care Costs; Hospital Costs; Hospitalization; Humans; Male; Medicare; Middle Aged; Myocardial Infarction; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial.
Topics: Adult; Aged; Antidepressive Agents; Assertiveness; Cognitive Behavioral Therapy; Combined Modality Therapy; Communication; Coronary Disease; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Personality Inventory; Sertraline; Social Support; Treatment Outcome | 2008 |
An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Sertraline Anti-Depressant Heart Attack Trial.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Canada; Depressive Disorder, Major; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline; Single-Blind Method; Time Factors; United States | 1999 |
Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction.
Topics: Acute Disease; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Sympathetic Nervous System; Treatment Outcome | 2001 |
16 other study(ies) available for sertraline and Cardiovascular Stroke
Article | Year |
---|---|
Impact of neonatal sertraline exposure on the post-myocardial infarction outcomes of adult male mice.
Topics: Animals; Animals, Newborn; Disease Models, Animal; Echocardiography; Hypoplastic Left Heart Syndrome; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Rate; Telemetry; Time Factors | 2013 |
Adverse cardiac events in older patients receiving venlafaxine: a population-based study.
Topics: Age Factors; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cohort Studies; Comorbidity; Cyclohexanols; Drug Interactions; Female; Heart Failure; Humans; Hypertension; Male; Myocardial Infarction; Ontario; Retrospective Studies; Risk Factors; Sertraline; Tachycardia; Venlafaxine Hydrochloride | 2014 |
Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline.
Topics: Animals; Antidepressive Agents; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Biomarkers; Caspase 3; Depression; DNA Fragmentation; Limbic System; Male; Myocardial Infarction; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sertraline | 2009 |
The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Topics: Aged; Antidepressive Agents; Chronic Disease; Defibrillators, Implantable; Depression; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Quality of Life; Refractory Period, Electrophysiological; Selective Serotonin Reuptake Inhibitors; Sertraline; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
[Stabilizing affective symptoms without adverse cardiac effects. Myocardial infarct risk after depression--and vice versa].
Topics: Affect; Antidepressive Agents; Depressive Disorder; Heart Rate; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2002 |
Treatment of depression following acute myocardial infarction.
Topics: Angina, Unstable; Depressive Disorder, Major; Humans; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Safe treatment for depression after heart attack.
Topics: Antidepressive Agents; Depression; Humans; Myocardial Infarction; Sertraline | 2002 |
Sertraline for treatment of depression in acute coronary syndromes.
Topics: Angina, Unstable; Antidepressive Agents; Depressive Disorder; Humans; Myocardial Infarction; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Ventricular Function, Left | 2002 |
Sertraline for treatment of depression in acute coronary syndromes.
Topics: Angina, Unstable; Antidepressive Agents; Depressive Disorder; Humans; Myocardial Infarction; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Ventricular Function, Left | 2002 |
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury.
Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; CHO Cells; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Humans; Iodine Radioisotopes; Isoxazoles; Myocardial Infarction; Myocardial Reperfusion Injury; Purines; Rabbits; Radioligand Assay; Receptor, Adenosine A3; Sertraline; Transfection | 2003 |
Antidepressants may temper heart-disease risk.
Topics: Antidepressive Agents; Depression; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline | 2003 |
Neurobiology of decreased heart rate variability in older patients with recent acute coronary syndrome.
Topics: Aged; Aging; Arrhythmias, Cardiac; Depressive Disorder; Heart Rate; Humans; Middle Aged; Myocardial Infarction; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Selective serotonin reuptake inhibitors (SSRIs) and depression after myocardial infarction (MI).
Topics: Depressive Disorder, Major; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Depression and panic disorder after heart transplantation--treatment with sertraline.
Topics: Antidepressive Agents; Depressive Disorder, Major; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Infarction; Panic Disorder; Sertraline | 2002 |
[The myocardial infarct patient. Screening for depression and treatment].
Topics: Depressive Disorder; Humans; Myocardial Infarction; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role | 2002 |